Differentiating Albinism from other diseases: Difference between revisions
(4 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Oculocutaneous albinism]] and [[ocular albinism]] must be differentiated from the following rare disease: [[Hermansky-Pudlak syndrome]], [[Chediak-Higashi syndrome]], [[Griscelli syndrome]], [[Waardenburg syndrome]] type II, [[Vici syndrome]], Tietz albinism-deafness syndrome, [[Angelman syndrome]], [[Prader-Willi syndrome]], Cross-McKusick-Breen syndrome, [[Achromatopsia]], Aland Island eye disease (Forsius-Eriksson syndrome), [[Aniridia]], and [[Congenital]] [[nystagmus]]. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Line 120: | Line 121: | ||
| style="background:#DCDCDC;" align="center" + | Aland Island eye disease (Forsius-Eriksson syndrome) | | style="background:#DCDCDC;" align="center" + | Aland Island eye disease (Forsius-Eriksson syndrome) | ||
| style="background:#F5F5F5;" + | [[X-linked recessive]] | | style="background:#F5F5F5;" + | [[X-linked recessive]] | ||
| style="background:#F5F5F5;" + | Novel CACNA1F gene mutation | | style="background:#F5F5F5;" + | Novel [[CACNA1F]] [[gene mutation]] | ||
| style="background:#F5F5F5;" + | | | style="background:#F5F5F5;" + | | ||
* fundal [[hypopigmentation]] | * fundal [[hypopigmentation]] | ||
Line 129: | Line 130: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + | [[Aniridia]] | | style="background:#DCDCDC;" align="center" + | [[Aniridia]] | ||
| style="background:#F5F5F5;" + | | | style="background:#F5F5F5;" + | [[ Autosomal dominant]] | ||
| style="background:#F5F5F5;" + | | | style="background:#F5F5F5;" + | [[PAX6]] [[gene mutation]] | ||
| style="background:#F5F5F5;" + | | | style="background:#F5F5F5;" + | | ||
* Absence of the [[iris]] | * Absence of the [[iris]] | ||
Line 140: | Line 141: | ||
| style="background:#DCDCDC;" align="center" + | [[Congenital]] [[nystagmus]] | | style="background:#DCDCDC;" align="center" + | [[Congenital]] [[nystagmus]] | ||
| style="background:#F5F5F5;" + | [[X-linked]] disorder | | style="background:#F5F5F5;" + | [[X-linked]] disorder | ||
| style="background:#F5F5F5;" + | FRMD7 gene mutation | | style="background:#F5F5F5;" + | [[FRMD7]] [[gene mutation]] | ||
| style="background:#F5F5F5;" + | | | style="background:#F5F5F5;" + | | ||
* [[Nystagmus]] | * [[Nystagmus]] |
Latest revision as of 23:21, 23 August 2021
Albinism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Differentiating Albinism from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating Albinism from other diseases |
Risk calculators and risk factors for Differentiating Albinism from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Oculocutaneous albinism and ocular albinism must be differentiated from the following rare disease: Hermansky-Pudlak syndrome, Chediak-Higashi syndrome, Griscelli syndrome, Waardenburg syndrome type II, Vici syndrome, Tietz albinism-deafness syndrome, Angelman syndrome, Prader-Willi syndrome, Cross-McKusick-Breen syndrome, Achromatopsia, Aland Island eye disease (Forsius-Eriksson syndrome), Aniridia, and Congenital nystagmus.
Differential Diagnosis
- Oculocutaneous albinism and ocular albinism must be differentiated from following disorders:[1][2][3][4][5][6][7][8][9]
References
- ↑ "Albinism - StatPearls - NCBI Bookshelf".
- ↑ Lee ST, Nicholls RD, Bundey S, Laxova R, Musarella M, Spritz RA (1994). "Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism". N Engl J Med. 330 (8): 529–34. doi:10.1056/NEJM199402243300803. PMID 8302318.
- ↑ HERMANSKY F, PUDLAK P (1959). "Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies". Blood. 14 (2): 162–9. PMID 13618373.
- ↑ DePinho RA, Kaplan KL (1985). "The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations". Medicine (Baltimore). 64 (3): 192–202. PMID 3921802.
- ↑ Witkop CJ, Nuñez Babcock M, Rao GH, Gaudier F, Summers CG, Shanahan F; et al. (1990). "Albinism and Hermansky-Pudlak syndrome in Puerto Rico". Bol Asoc Med P R. 82 (8): 333–9. PMID 2261023.
- ↑ Dimson O, Drolet BA, Esterly NB (1999). "Hermansky-Pudlak syndrome". Pediatr Dermatol. 16 (6): 475–7. doi:10.1046/j.1525-1470.1999.00122.x. PMID 10632950.
- ↑ Fukai K, Ishii M, Kadoya A, Chanoki M, Hamada T (1993). "Chédiak-Higashi syndrome: report of a case and review of the Japanese literature". J Dermatol. 20 (4): 231–7. doi:10.1111/j.1346-8138.1993.tb03867.x. PMID 8315113.
- ↑ Mancini AJ, Chan LS, Paller AS (1998). "Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature". J Am Acad Dermatol. 38 (2 Pt 2): 295–300. doi:10.1016/s0190-9622(98)70568-7. PMID 9486701.
- ↑ WAARDENBURG PJ (1951). "A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness". Am J Hum Genet. 3 (3): 195–253. PMC 1716407. PMID 14902764.